DOMINOS PIZZA ENTERPRISES LIMITED UNSP ADR EACH REPR 0.5 ORD SHS
DMZPY
LIFE HEALTHCARE GROUP HOLDINGS UNSPON ADR EA REPR 4 ORD ZAR0.00
LTGHY
Halozyme Therapeutics
HALO
Teradata Corp
TDC
Collegium Pharmaceutical
COLL
(Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Total revenue | -93.48%47.81K | -77.15%180.18K | 19.96%477.27K | -21.18%2.47M | 22.69%553.25K | 12.20%733.13K | -26.29%788.43K | -58.68%397.85K | 167.01%3.14M | 7.96%450.94K |
Operating revenue | -93.48%47.81K | -77.15%180.18K | 19.96%477.27K | -21.18%2.47M | 22.69%553.25K | 12.20%733.13K | -26.29%788.43K | -58.68%397.85K | 167.01%3.14M | 7.96%450.94K |
Cost of revenue | -89.62%425.06K | -56.71%1.64M | 25.77%4.48M | 12.11%15.28M | 6.93%3.84M | 16.42%4.1M | 16.64%3.79M | 8.66%3.56M | 26.38%13.63M | 16.73%3.59M |
Gross profit | 88.78%-377.25K | 51.34%-1.46M | -26.50%-4M | -22.06%-12.81M | -4.67%-3.28M | -17.38%-3.36M | -37.70%-3M | -36.69%-3.16M | -9.18%-10.49M | -18.11%-3.14M |
Operating expense | -26.81%1.98M | 4.38%3.59M | -19.19%2.68M | 22.64%14.51M | 69.14%5.03M | 1.47%2.71M | 1.48%3.44M | 19.01%3.32M | -5.44%11.83M | -12.12%2.98M |
Selling and administrative expenses | -23.54%1.93M | 8.11%3.53M | -19.83%2.56M | 26.34%13.8M | 80.48%4.82M | 3.08%2.53M | 2.51%3.26M | 21.91%3.2M | 5.41%10.93M | -3.09%2.67M |
-Selling and marketing expense | -76.98%44.17K | -58.97%79.7K | -67.74%63.96K | -30.11%795.93K | -40.40%211.53K | 2.93%191.86K | -44.49%194.25K | -19.91%198.29K | -9.75%1.14M | 84.45%354.9K |
-General and administrative expense | -19.15%1.89M | 12.36%3.45M | -16.66%2.5M | 32.91%13.01M | 99.01%4.6M | 3.10%2.33M | 8.32%3.07M | 26.27%3M | 7.51%9.79M | -9.67%2.31M |
Research and development costs | -71.72%52.09K | -63.84%64.5K | -2.54%119.79K | -22.14%703.82K | -29.10%218.29K | -16.49%184.22K | -14.35%178.39K | -26.48%122.92K | -57.87%903.98K | -51.37%307.9K |
Operating profit | 61.12%-2.36M | 21.59%-5.05M | -3.09%-6.68M | -22.37%-27.32M | -36.06%-8.32M | -9.70%-6.07M | -15.66%-6.44M | -27.02%-6.48M | -0.91%-22.32M | -1.16%-6.11M |
Net non-operating interest income expense | -1,517.28%-1.03M | -1,404.77%-989.98K | -214.70%-208.56K | -4.39%-303.97K | -57.02%-108.16K | 11.85%-63.75K | 11.92%-65.79K | 11.97%-66.27K | 7.98%-291.18K | 11.62%-68.88K |
Non-operating interest expense | 1,517.28%1.03M | 1,404.77%989.98K | 214.70%208.56K | 4.39%303.97K | 57.02%108.16K | -11.85%63.75K | -11.92%65.79K | -11.97%66.27K | -7.98%291.18K | -11.62%68.88K |
Other net income (expense) | -2,237.79%-12.06K | -13,558,619.51%-44.47M | -6,841.59%-4.27M | -86.30%62.67K | -99.80%225 | -100.31%-516 | -100.30%-328 | -6.06%63.28K | 295.71%457.52K | 114.97%112.17K |
Special income (charges) | --0 | ---44.47M | ---4.27M | ---- | ---- | --0 | --0 | --0 | ---- | ---- |
-Less:Impairment of capital assets | --0 | --44.47M | --4.27M | ---- | ---- | --0 | --0 | --0 | ---- | ---- |
Other non- operating income (expenses) | -2,237.79%-12.06K | -1,234.76%-4.38K | -102.13%-1.35K | -86.30%62.67K | -99.80%225 | -100.31%-516 | -100.30%-328 | -6.06%63.28K | 295.71%457.52K | 114.97%112.17K |
Income before tax | 44.54%-3.4M | -676.10%-50.51M | -72.03%-11.16M | -24.37%-27.56M | -38.81%-8.42M | -12.83%-6.14M | -17.57%-6.51M | -26.89%-6.49M | 0.74%-22.16M | -0.02%-6.07M |
Income tax | ||||||||||
Net income | 44.54%-3.4M | -676.10%-50.51M | -72.03%-11.16M | -24.37%-27.56M | -38.81%-8.42M | -12.83%-6.14M | -17.57%-6.51M | -26.89%-6.49M | 0.74%-22.16M | -0.02%-6.07M |
Net income continuous Operations | 44.54%-3.4M | -676.10%-50.51M | -72.03%-11.16M | -24.37%-27.56M | -38.81%-8.42M | -12.83%-6.14M | -17.57%-6.51M | -26.89%-6.49M | 0.74%-22.16M | -0.02%-6.07M |
Minority interest income | ||||||||||
Net income attributable to the parent company | 44.54%-3.4M | -676.10%-50.51M | -72.03%-11.16M | -24.37%-27.56M | -38.81%-8.42M | -12.83%-6.14M | -17.57%-6.51M | -26.89%-6.49M | 0.74%-22.16M | -0.02%-6.07M |
Preferred stock dividends | ||||||||||
Other preferred stock dividends | ||||||||||
Net income attributable to common stockholders | 44.54%-3.4M | -676.10%-50.51M | -72.03%-11.16M | -24.37%-27.56M | -38.81%-8.42M | -12.83%-6.14M | -17.57%-6.51M | -26.89%-6.49M | 0.74%-22.16M | -0.02%-6.07M |
Basic earnings per share | 45.00%-0.88 | -673.96%-13.08 | -71.60%-2.9 | -24.05%-7.17 | -38.61%-2.19 | -12.68%-1.6 | -5.62%-1.69 | -20.71%-1.69 | 9.69%-5.78 | 1.25%-1.58 |
Diluted earnings per share | 45.00%-0.88 | -673.96%-13.08 | -71.60%-2.9 | -24.05%-7.17 | -38.61%-2.19 | -12.68%-1.6 | -5.62%-1.69 | -20.71%-1.69 | 9.69%-5.78 | 1.25%-1.58 |
Dividend per share | ||||||||||
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion | -- |